These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12075860)

  • 1. Apraxia of eyelid closure in Huntington's disease.
    Bonelli RM; Niederwieser G
    J Neural Transm (Vienna); 2002 Feb; 109(2):197-201. PubMed ID: 12075860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole and olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Diez J; Költringer P
    Eur J Neurol; 2002 Mar; 9(2):183-4. PubMed ID: 11882065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Olanzapine improves chorea in patients with Huntington's disease].
    Jiménez-Jiménez FJ; de Toledo M; Puertas I; Barón M; Zurdo M; Barcenilla B
    Rev Neurol; 2002 Sep 16-30; 35(6):524-5. PubMed ID: 12389168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Tribl GG; Költringer P
    Int Clin Psychopharmacol; 2002 Mar; 17(2):91-3. PubMed ID: 11890191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine in Huntington's disease.
    Paleacu D; Anca M; Giladi N
    Acta Neurol Scand; 2002 Jun; 105(6):441-4. PubMed ID: 12027832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole in Huntington's disease (HD): an open label study with one year follow up.
    Seppi K; Mueller J; Bodner T; Brandauer E; Benke T; Weirich-Schwaiger H; Poewe W; Wenning GK
    J Neurol; 2001 Oct; 248(10):866-9. PubMed ID: 11697523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of olanzapine for movement disorder in Huntington's disease: a first case report.
    Dipple HC
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):123-4. PubMed ID: 10454874
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of Huntington's disease with olanzapine and valproate.
    Grove VE; Quintanilla J; DeVaney GT
    N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine and Huntington's disease.
    Bogelman G; Hirschmann S; Modai I
    J Clin Psychopharmacol; 2001 Apr; 21(2):245-6. PubMed ID: 11270928
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine for Huntington's disease: an open label study.
    Bonelli RM; Mahnert FA; Niederwieser G
    Clin Neuropharmacol; 2002; 25(5):263-5. PubMed ID: 12410058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report.
    Etchebehere EC; Lima MC; Passos W; Maciel Júnior JA; Santos AO; Ramos CD; Camargo EE
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):863-6. PubMed ID: 10751925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term therapy with intuition].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():87. PubMed ID: 14579492
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparable dopamine 2 receptor occupancy.
    de Haan L; van Amelsvoort T
    Am J Psychiatry; 2002 Dec; 159(12):2118; author reply 2118-9. PubMed ID: 12450982
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of hemichorea with olanzapine.
    Safirstein B; Shulman LM; Weiner WJ
    Mov Disord; 1999 May; 14(3):532-3. PubMed ID: 10348489
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():86-7. PubMed ID: 14579491
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study.
    Huntington Study Group
    Neurology; 2003 Dec; 61(11):1551-6. PubMed ID: 14663041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole therapy in Huntington's disease (HD).
    Rosas HD; Koroshetz WJ; Jenkins BG; Chen YI; Hayden DL; Beal MF; Cudkowicz ME
    Mov Disord; 1999 Mar; 14(2):326-30. PubMed ID: 10091628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN; Wasylink S; Epperson CN; McDougle CJ
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
    Potenza MN; Wasylink S; Longhurst JG; Epperson CN; McDougle CJ
    J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.